Healthcare industry

Article - 27/07/2015

Fraunhofer PAMB accelerates the development of medical devices

Dr. Auguste van Poelgeest is head of the “Control Systems for Medical Engineering” research group that is part of the Project Group for Automation in Medicine and Biotechnology (PAMB). The project group is based at the Fraunhofer Institute for Manufacturing Engineering and Automation IPA. In an interview with Dr. Ariane Pott from BIOPRO Baden-Württemberg, van Poelgeest explains the role of automation in the field of medicine and how…

As a 100% affiliate of the Baden-Württemberg government, BIOPRO Baden-Württemberg GmbH provides targeted support to the pharmaceutical industry and the biotechnology and medical technology sectors as well as supporting the development of a bioeconomy.

The latest articles, press releases and dossiers on medical technology in Baden-Württemberg

The latest articles, press releases and dossiers on pharmaceutics in Baden-Württemberg

Baden-Württemberg is home to numerous technology parks and thus offers an excellent infrastructure and attractive high-tech locations for life sciences companies in close proximity to scientific excellence. Young companies and business start-ups particularly stand to benefit from the opportunities for cooperation with other companies and research institutions in the technology parks and also from the relatively cheap rents for office and…

Setting up an independent company is an excellent way to turn innovative life sciences solutions into successful new products and services. Baden-Württemberg is highly attractive for business startups. As one of the leading German states in the fields of healthcare and biotechnology, Baden-Württemberg has an attractive and stimulating environment for those seeking to set up their own company. Baden-Württemberg has a high density of innovative…

Medical technology is indispensible for human health and contributes a great deal to improving the quality of our lives. The field of medical technology covers many areas. These range from simple disposable products and consumables such as dressing materials and other clinical supplies, to IT-related telemedicine, homecare and eHealth systems as well as high-technology and innovative robotics, imaging, diagnostics and life-support systems. 838…

The Baden-Württemberg healthcare industry – a recession-proof employer that has strong ties with the region - is of key importance for the state. It comprises the biotechnology and medical technology sectors and the pharmaceutical industry. In 2017, the industry with over 90,500 employees generated revenues of over 24 billion euros.

Article - 07/04/2015

How human lives can be saved by measuring respiratory flow

First aid at the site of an accident can save many lives. Initial assistance is very often given by non-experts. In order to help these first-aiders in what are difficult circumstances, Karl Küfner GmbH & Co. KG from Albstadt and the HSG-IMIT (Institut für Mikro- und Informationstechnik) from Villingen-Schwenningen have developed a respiratory flow sensor for first-aiders which gives visual and acoustic information during resuscitation.

Article - 15/12/2014

Heart muscle cell 1.0 and 2.0 – two epigenetic programmes in one cell

All the cells in an organism have to adapt to changing requirements as they develop and grow - including muscle cells in the heart. Crucial to this process are the cells’ growth in size and epigenetic factors that play a role in modulating the expression of various genes. The role of epigenetics in cancer development has been the focus of research for quite some time. The question is, what role do epigenetic factors play in the development of the…

Part 2 - 06/10/2014

Expert interview: How are the prices of innovative diagnostic and medical devices determined?

While there are specific regulations in Germany for the reimbursement of medicines, funding for molecular diagnostics products is complex and virtually non-existent. There is hardly any medical insurance cover for medical devices, which therefore tend to be sold on the open market. The question therefore arises as to how a reasonable price can be determined for innovative diagnostic methods and tools. In the second part of the interview conducted…

Article - 30/09/2014

Retrospective: 2014 Baden-Württemberg Healthcare Industry Forum

More than 190 people took up BIOPRO Baden-Württemberg GmbH and BioRegionUlm’s invitation to participate in the 2014 Baden-Württemberg Healthcare Industry Forum on 24th September 2014. The interdisciplinary meeting, which is the only one of its kind in Baden-Württemberg, took place in Ulm Congress Centre and specifically focused on the cooperation between different sectors in the healthcare industry, i.e. medical technology, biotechnology and the…

Article - 11/08/2014

PRONTO develops microsystems for and with companies

Since 2010, PRONTO, a project run by the MicroTEC Südwest cluster, has been focusing on the production of innovative microsystems for application in the medical and other sectors. PRONTO provides microsystems development support up to small-scale production. Customers who are seeking to implement their ideas into concrete microsystems solutions can count on the expertise and infrastructure of four institutes.

The Innovation Prize 2014 aims to promote innovation in the field of biotechnology. It targets medicines, medical devices, medical technologies and e-health solutions. The Innovation Prize is open to Academic researchers in the field of Life Sciences and Representatives from young companies. The winner will receive a reward of a combined value of 50,000€ including cash and consulting services provided by Universal Biotech during one year after…

Dossier - 31/03/2014

Peptides – diverse molecules of life

Peptides exist in all organisms, wherever there are cells. The range of their physiological functions is huge. Biologically active peptides can act as hormones, neurotransmitters, growth factors as well as toxins and antibiotics. This is what makes them highly interesting drug leads. They are used for the treatment of autoimmune diseases, cancer and other diseases. Despite some drawbacks, peptides are gaining in importance as candidates for drugs…

Article - 03/02/2014

Verapido Medical GmbH: small needles with a huge effect

Verapido Medical GmbH is a medical device company based in Villingen-Schwenningen (Germany) that develops and manufactures devices with which liquid drugs can be administered intradermally, i.e. into the skin rather than below the skin. The company’s microneedle technology looks to have several advantages over existing drug delivery methods, including better effect, less pain for the patient and lower costs.

Article - 20/01/2014

Curetis AG: Miniaturised laboratory for the simple, rapid and reliable diagnosis of serious infections

Acute pneumonia usually leaves doctors with no choice the situation can quickly become life threatening requiring doctors to act quickly. Instead of waiting for laboratory results they often prescribe an antibiotic that is effective against numerous bacterial species in the hope that it will also work against the bacterium that has caused the inflammation in the lung tissue. Curetis AG from Holzgerlingen close to Stuttgart has developed a…

Article - 16/12/2013

Cellendes puts paradigm change in cell research to good use

Cells grown on the flat furfaces of tissue culture plates do not behave as they would in their natural environment. This is why scientists are now using three-dimensional substrates to replicate the natural environmental of cells in tissue cellular matrix. Dr. Brigitte Angres and Dr. Helmut Wurst founders and managing directors of Cellendes GmbH in Reutlingen have taken advantage of this new knowledge and developed two novel hydrogels for cell…

Article - 09/12/2013

KVART – a hospital bed with built-in intelligence

Exercise is the best medicine! this was the maxim adopted by Dr. Clemens Gutknecht and Dr. Josef Schönberger when they were investigating the treatment remobilisation and care of bedridden patients. The findings of the two experienced neurologists led to the development of a concept for an intelligent hospital bed. Based on a patented technology and quantitative market potential estimates Gutknecht and Schönberger have established KVART GmbH in…

On 05.12.2013, the NMI holds a workshop in the NMI Innovation Forum in Reutlingen about "sticking and checking in medical technology in 2013." The event to innovative joining, testing and coating process for medical technology takes place from 1 till 5 pm. The application is possible till 29.11.2013. The attendance fee is 20 euros.

Article - 02/09/2013

Sectio chirurgica: live and interactive anatomy

Telemedical teaching is taking off: Tübingen’s Sectio chirurgica (TSC) is already used by around 25% of all medical students in German-speaking countries. TSC transmits surgical interventions and procedures performed by renowned surgeons into auditoriums and via Internet live stream.

Article - 08/07/2013

Götz Gresser - new director of the ITV Denkendorf

Dr.-Ing. Götz Gresser succeeds Prof. Dr.-Ing. Heinrich Planck as director of the Institute of Textile Technology and Process Engineering (ITV) Denkendorf. Gresser regards the application-oriented research and development in the fields of medical technology and biotechnology as an important success factor of the institute and will continue to further develop this.

Article - 12/03/2013

Science to business – exit strategies for biotech companies

The two directors of the consultancy firm LSCN Ltd. Dr. Alrik Koppenhöfer and Dr. Volker Ungermann explain the key issues involved in MA negotiations and licensing deals and how LSCN supports biotechnology companies and strategic investors in reaching their goals. Both managers agree that a good dose of realism is necessary.

Article - 04/03/2013

Nano-design inspired by nature enables cells to interact with implants

Eye implants that communicate with living cells have the potential to spare many patients from having to undergo further eye surgery or laser treatment. However, Christian Lingenfelder, managing director of Dornstadt-based Alamedics, believes that it will take at least five to seven years for the idea to become reality and a medical product placed on the market. Alamedics, which was founded in 2012, has already made an important initial step in…

Article - 11/02/2013

Quality management: burden or opportunity?

Companies are facing increasing demands. Globalisation and an increasingly quality-conscious market increase competition and pricing pressure. To remain globally competitive companies need a product and service quality that will satisfy the customer in the long term. Alexander Cansier managing director of OrgaConnect GmbH has specialised in the support of small and medium-sized companies in the life sciences pharmaceutical and medical technology…